Mathew Lonberg is a Hematology physician affiliated with Nyack Hospital. OpenAlex indexes 8 publications with 287 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.8%Kinase inhibitor15%Imbruvica34%Jakafi34%Calquence13%Cotellic11%Ibrance9%Part D<11 patientsAromatase Inhibitor14.8%Anastrozole56%Exemestane30%Letrozole15%Part D<11 patients+ 4 more classes in this area
Blood & clotting
29.1%Factor Xa inhibitor22.1%Eliquis84%Xarelto16%Part D<11 patientsVitamin K antagonist5.5%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Dermatology
7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor7%Acyclovir100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Validation of a study design that promotes diversity in clinical trials.
Journal of Clinical Oncology
2025 - 7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086
European Journal of Cancer Supplements
2009 - Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia
Leukemia & lymphoma/Leukemia and lymphoma
2003
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”